ClinicalTrials.gov record
Recruiting No phase listed Observational

A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)

ClinicalTrials.gov ID: NCT07001280

Public ClinicalTrials.gov record NCT07001280. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 9:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Garadacimab Real-world Treatment Outcomes of Effectiveness, Safety, and Quality-of-Life in Patients With HAE (GREAT Study)

Study identification

NCT ID
NCT07001280
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
CSL Behring
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

  • No intervention Other

Other

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 20, 2025
Primary completion
Aug 30, 2028
Completion
Aug 30, 2030
Last update posted
Mar 26, 2026

2025 – 2030

United States locations

U.S. sites
5
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
Medical Research of Arizona Phoenix Arizona 85248 Recruiting
Asthma and Allergy Wellness Center Saint Charles Illinois 60175-4827 Recruiting
John Hopkins University Baltimore Maryland 21287 Active, not recruiting
Washington University St Louis Missouri 63141 Active, not recruiting
Riverside Medical Group, Belleville Belleville New Jersey 07109 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07001280, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 26, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07001280 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →